Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes

Infection and Immunity

Volumn 65, Issue 6, 1997, Pages 2272-2277

  Troelstra, Annet ^a   Antal Szalmas, Peter ^a,b   De Graaf Miltenburg, Lia A M ^a   Weersink, Annemarie J L ^a   Verhoef, Jan ^a   Van Kessel, Kok P M ^a   Van Strijp, Jos A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; FLUORESCEIN; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE;

ANTIGEN BINDING; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030922207     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.6.2272-2277.1997     Document Type: Article

References (43)

1. Bazil, V., V. Horesji, M. Baudys, H. Kristofova, J. L. Strominger, W. Kostka, and I. Hilgert. 1986. Biochemical characterisation of a soluble form of the 53-kDa monocyte surface antigen. Eur. J. Immunol. 16:1583-1589.
2. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 114:457- 469.
3. Brade, H., C. Galanos, and O. Lüderitz. 1983. Differential determination of the 3-deoxy-d-mannooctulosonic acid residues in lipopolysaccharides of Salmonella minnesota rough mutants. Eur. J. Biochem. 131:195-200.
4. Brade, H., and C. Calanos. 1983. A method to detect 2-keto-3-deoxyoctanat and related compounds on pherograms and chromatograms. Anal. Biochem. 132:158-159.
5. Cooper, N. R., and D. C. Morrison. 1978. Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J. Immunol. 120:1862-1868.
6. Corrales, I., A. J. Weersink, J. Verhoef, and K. P. van Kessel. 1993. Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14. Immunology 80:84-89.
7. Couturier, C., N. Haeffner-Cavaillon, M. Caroff, and M. D. Kazatchkine. 1991. Binding sites for endotoxins (lipopolysaccharides) on human monocytes. J. Immunol. 147:1899-1904.
8. Din, Z. Z., P. Mukerjee, M. Kastowsky, and K. Takayama. 1993. Effect of pH on solubility and ionic state of lipopolysaccharide obtained from the deep rough mutant of Escherichia coli. Biochemistry 32:4579-4586.
9. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665-1671.
10. Gegner, J. A., R. J. Ulevitch, and P. S. Tobias. 1995. Lipopolysaccharide (LPS) signal transduction and clearance. J. Biol. Chem. 270:5320-5325.
11. Haeffner-Cavaillon, N., R. Chaby, J.-M. Cavaillon, and L. Szabó. 1982. Lipopolysaccharide receptor on rabbit peritoneal macrophages. I. Binding characteristics. J. Immunol. 128:1950-1955.
12. Haziot, A., S. Chen, E. Ferrero, M. G. Low, R. Silber, and S. M. Goyert. 1988. The monocyte differentiation antigen. CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141:547-552.
13. Haziot, A., G. W. Rong, J. Silver, and S. M. Goyert. 1993. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1500-1507.
14. Haziot, A., G. W. Rong, V. Bazil, J. Silver, and S. M. Goyert. 1994. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor α production by cells in whole blood. J. Immunol. 152:5868-5876.
15. Heumann, D., P. Gallay, C. Barras, P. Zaech, R. J. Ulevitch, P. S. Tobias, M.-P. Glauser, and J. D. Baumgartner. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148:3505-3512.
16. Heumann, D., P. Gallay, S. Betz Corradin, C. Barras, J. D. Baumgartner, and M. P. Glauser. 1993. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes. J. Infect. Dis. 167:1351-1357.
17. Hirata, M., Y. Shimomura, M. Yoshida, J. G. Morgan, I. Palings, D. Wilson, M. H. Yen, S. C. Wright, and J. W. Larrick. 1994. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect.Immun. 62:1421-1426.
18. Horwitz, A. H., R. E. Williams, and G. Nowakowski. 1995. Human lipopolysaccharidebinding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein. Infect. Immun. 63:522-527.
19. Kirkland, T. N., F. Finley, D. Leturcq, A. Moriarty, J. D. Lee, R. J. Ulevitch, and P. S. Tobias. 1993. Analysis of lipopolysaccharide binding by CD14. J. Biol. Chem. 268:24818-24823.
20. Kitchens, R. L., and R. S. Munford. 1995. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 270:9904-9910.
21. Kitchens, R. L., R. J. Ulevitch, and R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176:485-494.
22. Kruger, C., C. Schutt, U. Obertacke, T. Joka, F. E. Muller, J. Knoller, M. Koller, W. Konig, and W. Schonfeld. 1991. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 85:297-301.
23. Landman, R., W. Zimmerli, S. Sansano, S. Link, A. Hahn, M. P. Glauser, and T. Calandra. 1995. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J. Infect. Dis. 171:639-644.
24. Larrick, J. W., M. Hirata, R. F. Balint, J. Lee, J. Zhong, and S. C. Wright. 1995. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63:1291-1297.
25. Larrick, J. W., M. Hirata, H. Zheng, J. Zhong, D. Bolin, J. M. Cavaillon, H. S. Warren, and S. D. Wright. 1994. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J. Immunol. 152:231-240.
26. Meager, A., S. Parti, H. Leung, E. Peil, and B. Mahon. 1987. Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF). Hybridoma 6:305-311.
27. Pollack, M., A. M. Espinoza, G. Gucide, N. L. Koles, L. M. Wahl, and C. A. Ohl. 1995. Lipopolysaccharide (LPS)-specific monoclonal antibodies regulate LPS uptake and LPS-induced tumor necrosis factor-α responses by human monocytes. J. Infect. Dis. 172:794-804.
28. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431.
29. Schutt, C., T. Schilling, U. Grunwald, W. Schonfeld, and C. Kruger. 1992. Endotoxin-neutralizing capacity of soluble CD14. Res. Immunol. 143:71-78.
30. Shnyra, A., K. Hultenby, and A. A. Lindberg. 1993. Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties. Infect. Immun. 61:5351-5360.
31. Skelly, R. R., P. Munkenbeck, and D. C. Morrison. 1979. Stimulation of T-independent antibody responses by hapten-lipopolysaccharides without repeating polymeric structure. Infect. Immun. 23:287-293.
32. Takayama, K., D. H. Mitchell, Z. Z. Din, P. Mukerjee, C. Li, and D. L. Coleman. 1994. Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the Limulus amebocyte lysate assay and in inducing Egr-1 mRNA in murine peritoneal macrophages. J. Biol. Chem. 269:2241-2244.
33. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1986. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164: 777-793.
34. Troelstra, A., B. N. G. Giepmans, K. P. M. van Kessel, H. S. Lichenstein, J. Verhoef, and J. A. G. van Strijp. 1997. Dual effects of soluble CD14 on LPS priming of neutrophils. J. Leukocyte Biol. 61:173-178.
35. Ulevitch, R. J. 1993. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv. Immunol. 53:267-289.
36. 125I-lipopolysaccharide. Infect. Immun. 60:5145-5152.
37. Van Deventer, J. H., H. R. Buller, J. W. Ten Cate, A. Sturk, and W. Pauw. 1988. Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet 1:605-608.
38. Warner, S. J. C., N. Savage, and D. Mitchell. 1985. Characteristics of lipopolysaccharide interaction with human peripheral-blood monocytes. Biochem. J. 232:379-383.
39. Weersink, A. J. L., K. P. M. van Kessel, R. Torensma, J. A. G. van Strijp, and J. Verhoef. 1990. Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibodies. J. Immunol. 145: 318-324.
40. Wilde, C. G., J. J. Seilhamer, M. McGrogan, N. Ashton, J. L. Snable, J. C. Lane, S. R. Leong, M. B. Thornton, K. L. Miller, and R. W. Scottl. 1994. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)- binding protein. LPS binding properties and effects on LPS-mediated cell activation. J. Biol. Chem. 269:17411-17416.
41. Wright, S. D., P. S. Tobias, R. J. Ulevitch, and R. A. Ramos. 1989. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170:1231- 1241.
42. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
43. Wurfel, M. M., S. T. Kunitake, H. Lichenstein, J. P. Kane, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180:1025- 1035.